Related Experiment Video
Updated: Dec 16, 2025
06:59
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
418
[Antithrombotic therapy after iliac vein stenting]
Wen Zhong1, Yan Lou1, Chenyang Qiu2
1Department of Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Summary
Antithrombotic therapy after iliac vein stenting lacks consensus. This review outlines medication strategies for non-thrombotic, acute thrombotic, and chronic thrombotic patients to improve stent patency and outcomes.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Hematology
Background:
- Iliac vein stenting is a common treatment for stenosis or compression.
- Optimal antithrombotic therapy post-stenting remains undefined.
- Patient prognosis varies significantly based on thrombotic status.
Purpose of the Study:
- To review current antithrombotic strategies for iliac vein stenting.
- To delineate optimal medication plans for different patient subgroups.
- To improve outcomes following iliac vein stenting procedures.
Main Methods:
- Literature review of studies on antithrombotic therapy after iliac vein stenting.
- Analysis of patient outcomes based on thrombotic status (non-thrombotic, acute thrombotic, chronic thrombotic).
- Evaluation of different antithrombotic medication regimens.
Main Results:
- Non-thrombotic patients generally achieve good stent patency regardless of therapy.
- Anticoagulation is standard for acute thrombotic cases; antiplatelet benefits are unclear.
- Chronic thrombotic patients show poor prognoses across all antithrombotic strategies.
Conclusions:
- Tailored antithrombotic therapy is crucial for optimizing iliac vein stenting outcomes.
- Further research is needed to clarify the role of antiplatelets in acute thrombotic scenarios.
- Developing effective strategies for chronic thrombotic patients remains a significant challenge.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
191
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
191
01:30Venous Thrombosis IV: Nursing Management
138
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
138
01:30Venous Thrombosis I: Introduction
177
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
177
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
196
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
196
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
100
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
100
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K